Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.21.1
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Changes and Error Corrections [Abstract]  
Summary of Reconciliation of the Consolidated Balance Sheets, Consolidated Statements of Operations and Consolidated Cash Flows from the Prior Periods to the Restated Amounts

The following presents a reconciliation of the Balance Sheets, Statements of Operations, and Statements of Cash Flows from the prior periods as previously reported to the restated amounts as of June 30, 2020 and December 31, 2019. The Statements of Shareholders’ Equity for the three and six month period ended June 30, 2020 and 2019 have been restated respectively, for the restatement impact to net (loss) income and common stock subject to possible redemption. See the Statements of Operations reconciliation tables below for additional information on the restatement and impact to net (loss) income.

 

     June 30, 2020  
     As Reported      Restatement
Adjustments
    As Restated  

Assets:

       

Current assets:

       

Cash

   $ 1,261,642    $ —       $ 1,261,642

Prepaid expenses

     83,333      —         83,333
  

 

 

    

 

 

   

 

 

 

Total current assets

     1,344,975      —         1,344,975

Investments held in Trust Account

     293,168,737      —         293,168,737
  

 

 

    

 

 

   

 

 

 

Total assets

   $ 294,513,712    $ —       $ 294,513,712
  

 

 

    

 

 

   

 

 

 

Liabilities and Shareholders’ Equity:

       

Current liabilities:

       

Accounts payable

   $ 26,078    $ —       $ 26,078

Accrued expenses

     25,000      —         25,000
  

 

 

    

 

 

   

 

 

 

Total current liabilities

     51,078      —         51,078

Warrant liability

     —          19,990,000   (a)      19,990,000

Deferred underwriting commissions

     9,187,500      —         9,187,500
  

 

 

    

 

 

   

 

 

 

Total liabilities

     9,238,578      19,990,000       29,228,578
  

 

 

    

 

 

   

 

 

 

Commitments and contingencies

       

Ordinary shares, $0.0001 par value; 28,750,000 shares subject to possible redemption at $10.00 per share at June 30, 2020

     280,275,130      7,224,870   (a)      287,500,000

Shareholders’ Equity:

       

Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

     —          —         —    

Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 7,187,500 shares issued and outstanding (excluding 28,750,000 shares subject to possible redemption) at $10.00 per share at June 30, 2020

     791      (72 ) (a)      719

Additional paid-in capital

     —          —         —    

Retained earnings / (Accumulated deficit)

     4,999,213      (27,214,798 ) (a)      (22,215,585
  

 

 

    

 

 

   

 

 

 

Total shareholders’ equity

     5,000,004      (27,214,870     (22,214,866
  

 

 

    

 

 

   

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 294,513,712    $ —       $ 294,513,712
  

 

 

    

 

 

   

 

 

 

 

     December 31, 2019  
     As Reported      Restatement
Adjustments
    As Restated  

Assets:

       

Current assets:

       

Cash

   $ 1,589,795    $ —       $ 1,589,795

Prepaid expenses

     62,738      —         62,738
  

 

 

    

 

 

   

 

 

 

Total current assets

     1,652,533      —         1,652,533

Investments held in Trust Account

     292,054,158      —         292,054,158
  

 

 

    

 

 

   

 

 

 

Total assets

   $ 293,706,691    $ —       $ 293,706,691
  

 

 

    

 

 

   

 

 

 

Liabilities and Shareholders’ Equity:

       

Current liabilities:

       

Accounts payable

   $ 86,595    $ —       $ 86,595

Accrued expenses

     8,860      —         8,860
  

 

 

    

 

 

   

 

 

 

Total current liabilities

     95,455      —         95,455

Warrant liability

     —          18,817,500   (a)      18,817,500

Deferred underwriting commissions

     9,187,500      —         9,187,500
  

 

 

    

 

 

   

 

 

 

Total liabilities

     9,282,955      18,817,500       28,100,455
  

 

 

    

 

 

   

 

 

 

Commitments and contingencies

       

Ordinary shares, $0.0001 par value; 28,750,000 shares subject to possible redemption at $10.00 per share at December 31, 2019

     279,423,730      8,076,270   (a)      287,500,000

Shareholders’ Equity:

       

Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

     —          —         —    

Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 7,187,500 shares issued and outstanding (excluding 28,750,000 and shares subject to possible redemption) at $10.00 per share at December 31, 2019

     800      (81 ) (a)      719

Additional paid-in capital

     775,141      (775,141 ) (a)      —    

Retained earnings / (Accumulated deficit)

     4,224,065      (26,118,548 ) (a)      (21,894,483
  

 

 

    

 

 

   

 

 

 

Total shareholders’ equity

     5,000,006      (26,893,770     (21,893,764
  

 

 

    

 

 

   

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 293,706,691    $ —       $ 293,706,691
  

 

 

    

 

 

   

 

 

 

 

The following tables contain the restatement of previously reported unaudited Statements of Operations for the three and six month periods ended June 30, 2020 and 2019.

 

     For the three months ended June 30, 2020  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 96,052   $ —       $ 96,052
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (96,052     —         (96,052

Loss on revaluation of warrant liability

     —         (6,936,250 ) (a)      (6,936,250

Loss on marketable securities, dividends and interest held in Trust Account

     (14,168     —         (14,168
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (110,220   $ (6,936,250   $ (7,046,470
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Public Shares

   $ —     $ (0.20 ) (a)    $ (0.20
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.01   $ (0.19 ) (a)    $ (0.20
  

 

 

   

 

 

   

 

 

 
     For the three months ended June 30, 2019  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 120,491   $ —       $ 120,491
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (120,491     —         (120,491

Issuance costs allocated to the public warrants

     —         (648,239 ) (a)      (648,239

Gain on revaluation of warrant liability

     —         3,617,500   (a)      3,617,500

Gain on marketable securities, dividends and interest held in Trust Account

     1,760,594     —         1,760,594
  

 

 

   

 

 

   

 

 

 

Net income

   $ 1,640,103   $ 2,969,261     $ 4,609,364
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net income per share, Public Shares

   $ 0.06   $ 0.27   (a)    $ 0.33  
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.02   $ (0.65 ) (a)    $ (0.67
  

 

 

   

 

 

   

 

 

 

 

     For the six months ended June 30, 2020  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 263,181   $ —       $ 263,181
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (263,181     —         (263,181

Loss on revaluation of warrant liability

     —         (1,172,500 ) (a)      (1,172,500

Gain on marketable securities, dividends and interest held in Trust Account

     1,114,579     —         1,114,579
  

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 851,398   $ (1,172,500   $ (321,102
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net income (loss) per share, Public Shares

   $ 0.04   $ (0.04 ) (a)    $ —  
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.04   $ —     (a)    $ (0.04
  

 

 

   

 

 

   

 

 

 
     For the six months ended June 30, 2019  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 134,230   $ —       $ 134,230
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (134,230     —         (134,230

Issuance costs allocated to the public warrants

     —         (648,239 ) (a)      (648,239

Gain on revaluation of warrant liability

     —         3,617,500   (a)      3,617,500

Gain on marketable securities, dividends and interest held in Trust Account

     1,760,594     —         1,760,594
  

 

 

   

 

 

   

 

 

 

Net income

   $ 1,626,364   $ 2,969,261     $ 4,595,625
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net income per share, Public Shares

   $ 0.06   $ 0.27   (a)    $ 0.33  
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.02   $ (0.65 )  (a)    $ (0.67
  

 

 

   

 

 

   

 

 

 

 

The following tables contain the restatement of previously reported unaudited Statements of Cash Flows for the three and six month periods ended June 30, 2020 and 2019.

 

     For the six months ended June 30, 2020  
     As Reported     Restatement
Adjustments
    As Restated  

Cash Flows from Operating Activities:

      

Net income (loss)

   $ 851,398   $ (1,172,500 ) (a)    $ (321,102

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

Gain on marketable securities, dividends and interest held in Trust Account

     (1,114,579     —         (1,114,579

Loss on revaluation of warrant liability

     —         1,172,500   (a)      1,172,500

Changes in operating assets and liabilities:

      

Prepaid expenses

     (20,595     —         (20,595

Accounts payable

     (60,517     —         (60,517

Accrued expenses

     16,140     —         16,140
  

 

 

   

 

 

   

 

 

 

Net cash used in operating activities

     (328,153 )      —         (328,153 ) 
  

 

 

   

 

 

   

 

 

 

Net change in cash

     (328,153     —         (328,153

Cash - beginning of period

     1,589,795     —         1,589,795
  

 

 

   

 

 

   

 

 

 

Cash - end of period

   $ 1,261,642   $ —       $ 1,261,642
  

 

 

   

 

 

   

 

 

 

Supplemental disclosure of noncash activities:

      

Remeasurement of ordinary shares subject to possible redemption

   $ 851,400   $ (851,400 ) (a)    $ —  

 

     For the six months ended June 30, 2019  
     As Reported     Restatement
Adjustments
    As Restated  

Cash Flows from Operating Activities:

      

Net income

   $ 1,626,364   $ 2,969,261   (a)    $ 4,595,625

Adjustments to reconcile net income to net cash used in operating activities:

 

General and administrative expenses paid by related party

     2,206     —         2,206

Gain on marketable securities, dividends and interest held in Trust Account

     (1,760,594     —         (1,760,594

Gain on revaluation of warrant liability

     —         (3,617,500 ) (a)      (3,617,500

Changes in operating assets and liabilities:

      

Prepaid expenses

     (138,629     —         (138,629

Accrued expenses

     82,575     —         82,575
  

 

 

   

 

 

   

 

 

 

Net cash used in operating activities

     (188,078 )      (648,239 )      (836,317 ) 
  

 

 

   

 

 

   

 

 

 

Cash Flows from Investing Activities:

      

Cash deposited in Trust Account

     (287,500,000     —         (287,500,000
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (287,500,000 )      —         (287,500,000 ) 
  

 

 

   

 

 

   

 

 

 

Cash Flows from Financing Activities:

      

Proceeds from note payable to related party

     250,000     —         250,000

Repayment of note payable and advances from related party

     (252,206     —         (252,206

Proceeds received from initial public offering

     287,500,000     —         287,500,000

Proceeds from private placement

     7,750,000     —         7,750,000

Offering costs paid

     (5,800,229     648,239   (a)      (5,151,990
  

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     289,447,565     648,239       290,095,804
  

 

 

   

 

 

   

 

 

 

Net change in cash

     1,759,487     —         1,759,487

Cash - beginning of period

     25,000     —         25,000
  

 

 

   

 

 

   

 

 

 

Cash - end of period

   $ 1,784,487   $ —       $ 1,784,487
  

 

 

   

 

 

   

 

 

 

Supplemental disclosure of noncash activities:

      

Offering costs included in accrued expenses

   $ 85,000   $ —       $ 85,000

Offering costs included in accounts payable

   $ 2,600   $ —       $ 2,600

Remeasurement of ordinary shares subject to possible redemption

   $ 276,823,340   $ (250,033,750 ) (a)    $ 26,789,590

Deferred underwriting commissions

   $ —       $ 9,187,500   (a)    $ 9,187,500  

 

(a) 

The Restatement Adjustments reflect the entries to record the initial liability for the Public and Private Warrants issued as part of Replay’s initial public offering and private placement, respectively, and to account for the adjustment to fair value of this liability at the end of each period presented. The initial fair value of the Public and Private Warrants of $19.3 million was recorded in April 2019 as a warrant liability with an offset to additional paid-in capital. In addition, the initial adjusting entry was also to expense approximately $648 thousand of costs directly associated with the issuance of the Public Warrants. The proceeds received from the sale of private warrants in excess of their fair value of $775 thousand was recognized as additional paid-in capital. For each subsequent quarter end, starting with June 30, 2019, the liability was revalued and the change in fair value reflected in “Gain/loss on revaluation of warrant liability” in the Statements of Operations. The Restatement Adjustment also reflect the impact of the remeasurement as of June 30, 2019 of the redeemable shares classified in temporary equity to align with the expected redemption amount of $287.5 million, the impact of the remeasurement of approximately $26.8 million was recognized as increase to the temporary equity balance with the offset to additional paid in capital and accumulated deficit. Additionally, the redemption amount was increased by the gains on marketable securities, dividends and interest held in the trust account, which is also subject to redemption by the ordinary shareholders. Lastly, the earning per share for both the Public and Founder shares was adjusted to account for the measurement adjustment to the temporary equity in accordance with the two classes of shares method and the guidance in ASC 480-10-S99-3A.